81 related articles for article (PubMed ID: 1065863)
1. [Refractory anemias with partial myeloblastosis. Analysis of a protocol comprising 79 cases. 1. Clinical characteristics and evolution under androgen therapy].
Najean Y; Pecking A; Broquet M
Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):67-80. PubMed ID: 1065863
[TBL] [Abstract][Full Text] [Related]
2. Refractory anaemia with excess of myeloblasts in the bone marrow: a clinical trial of androgens in 90 patients.
Najean Y; Pecking A
Br J Haematol; 1977 Sep; 37(1):25-33. PubMed ID: 271013
[TBL] [Abstract][Full Text] [Related]
3. Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias.
Scand J Haematol; 1986 Apr; 36(4):346-52. PubMed ID: 2872720
[TBL] [Abstract][Full Text] [Related]
4. [Refractory anemia with partial myeloblastic medullary infiltration. Examination of marrow biopsies (author's transl)].
Duhamel G; Muratore R; Bryon P
Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):81-6. PubMed ID: 1065864
[TBL] [Abstract][Full Text] [Related]
5. [Is aplastic anaemia a pre-leukaemic state? (author's transl)].
Nouv Presse Med; 1981 Dec; 10(46):3775-8. PubMed ID: 6948281
[TBL] [Abstract][Full Text] [Related]
6. Androgen therapy of aplastic anaemia--a prospective study of 352 cases.
Scand J Haematol; 1979 Apr; 22(4):343-56. PubMed ID: 472658
[TBL] [Abstract][Full Text] [Related]
7. Androgen therapy of aplastic anaemia.
Gardner FH
Clin Haematol; 1978 Oct; 7(3):571-85. PubMed ID: 363329
[TBL] [Abstract][Full Text] [Related]
8. Preleukemic states. I. Definition and classification. II. Refractory anemia with an excess of myeloblasts in the bone marrow (smoldering acute leukemia).
Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1976; 17(1-2):33-55. PubMed ID: 1005106
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and evolution of acquired aplastic anemia in childhood. A prospective analysis of 48 androgen-treated cases.
Najean Y; Girot R; Baumelou E
Am J Pediatr Hematol Oncol; 1982; 4(3):273-83. PubMed ID: 6756191
[TBL] [Abstract][Full Text] [Related]
10. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
11. [Sideroblastic anemia complicating aplastic anemia].
Sultan C; Cosson A; Priolet G; Dreyfus B
Nouv Presse Med; 1972 Feb; 1(7):443-5. PubMed ID: 4501570
[No Abstract] [Full Text] [Related]
12. [Treatment of aplastic anemia with antilymphocyte globulin, high-dose methylprednisolone and androgen].
Kojima S; Miyajima Y; Fukuda M; Matsuyama T; Maeda H; Yamamoto K; Tsuzuki S; Akatsuka M; Sugihara T; Minami S
Rinsho Ketsueki; 1992 Jan; 33(1):11-6. PubMed ID: 1545510
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia following seven years of aplastic anemia induced by chloramphenicol.
Cohen T; Creger WP
Am J Med; 1967 Nov; 43(5):762-70. PubMed ID: 5234001
[No Abstract] [Full Text] [Related]
14. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of aplastic anemia: a prospective multicenter study.
Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
[TBL] [Abstract][Full Text] [Related]
16. Problems in androgen treatment in aplastic anemia with reference to androgen dependency and acquisition of refractoriness.
Yoshida Y; Yamagishi M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1360-72. PubMed ID: 7342642
[No Abstract] [Full Text] [Related]
17. [Acquired aplastic anemia in children. Therapy using androgens and antilymphocyte gamma globulin].
Vilalta R; Ortega JJ; Javier G; Tusell J
An Esp Pediatr; 1984 Feb; 20(2):91-9. PubMed ID: 6370064
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of aplastic anemia with cyclosporine, prednisolone and androgens (primary results apropos of 10 cases].
Frikha M; Sahnoun Z; Kaabachi S; Elloumi M; Gargouri J; Dammak J; Zeghal KM; Souissi T
Therapie; 1996; 51(6):627-9. PubMed ID: 9163998
[TBL] [Abstract][Full Text] [Related]
19. Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias.
Najean Y; Pecking A
Cancer; 1979 Dec; 44(6):1976-82. PubMed ID: 389402
[TBL] [Abstract][Full Text] [Related]
20. Correlation between in vitro and in vivo response to androgens in patients with aplastic anemia.
Kamamoto T; Ohkubo T; Yamagishi M; Yoshida Y; Uchino H
Int J Cell Cloning; 1984 May; 2(3):173-84. PubMed ID: 6736687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
